Price Alert

Ventyx Biosciences Inc. (VTYX)

NASDAQ: VTYX · Real-Time Price · USD

2.52

-0.08 (-3.08%)

At close: Sep 05, 2025, 3:59 PM

2.52

0.00%

Pre-market: Sep 08, 2025, 07:00 AM EDT

-3.08% (1D)

Bid	2.48
Market Cap	179.7M
Revenue (ttm)	1.45M
Net Income (ttm)	-119.03M
EPS (ttm)	-1.67
PE Ratio (ttm)	-1.51
Forward PE	-1.35
Analyst	Hold

Ask	2.68
Volume	428,550
Avg. Volume (20D)	1,258,206
Open	2.63
Previous Close	2.60
Day's Range	2.50 - 2.67
52-Week Range	0.78 - 3.39
Beta	0.95

About VTYX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VTYX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VTYX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

11 months ago

+6.96%

Ventyx Biosciences shares are trading higher after... Unlock content with Pro Subscription

News

1 month ago · fool.com

Ventyx (VTYX) Q2 Net Loss Drops 16%

Ventyx Biosciences (VTYX -6.72%), a clinical-stage biopharmaceutical company focused on developing treatments for inflammatory and neurodegenerative diseases, released its second-quarter 2025 results ...

2 months ago · zacks.com

Ventyx Biosciences (VTYX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Ventyx Biosciences (VTYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).